TP53 and breast carcinoma: Notably, TACC3 expression significantly correlates with CC score in mut-p53-bearing tumors (Supplementary Fig. S5C, F, I), and breast cancer patients with mut-p53 and high TACC3 expression demonstrate much worse overall survival as compared to patients with low TACC3 expression (Fig. 4D).